NCT06399055View on ClinicalTrials.gov

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

September 16, 2022

Primary Completion Date

September 26, 2022

Study Completion Date

October 9, 2022

Conditions
Endocrine, Nutritional and Metabolic Diseases
Interventions
DRUG

CKD-387

1 Tablet

DRUG

D484

1 Tablet

Trial Locations (1)

Unknown

Bumin Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT06399055 - Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions | Biotech Hunter | Biotech Hunter